(WNDU) - Prostate cancer is one of the most common types of cancer in men, as almost 35,000 will die from it this year. It develops when abnormal cells form and grow in the prostate gland. Now, there ...
Zacks Investment Research on MSN
ANGO expands NanoKnife in Europe for multi-organ tumor ablation
AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical utility in soft tissue tumor ablation. The expanded approval covers NanoKnife’s ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
AngioDynamics, Inc. ANGO recently announced that Irreversible Electroporation (IRE) has received Current Procedural Terminology (CPT) Category I codes for the treatment of lesions in the prostate and ...
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
INDIANAPOLIS (WISH) — Prostate cancer is one of the most common types of cancer in men. Almost 35 thousand men will die from it this year. It develops when abnormal cells form and grow in the prostate ...
CLEVELAND, Oh. - It’s the leading cause of cancer deaths in men 65 and older. Traditional treatment includes chemotherapy, immunotherapy and radiation. Urologist Dr. Ruben Olivares specializes in ...
AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid first-quarter fiscal 2026 performance, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results